FeaturedHealthcareMindLight™: Pioneering the Future of Depression Care with Biomarker Precision
Introduction Depression remains a leading cause of disability worldwide, affecting millions and presenting significant challenges in treatment. Traditionally, selecting the right antidepressant involves an educated guessing process, which can prolong patient suffering and delay effective care. Enter MindLight™, an innovative antidepressant response test developed by Circular Genomics. By leveraging cutting-edge circular RNA (circRNA) biomarkers, MindLight Antidepressant Response Test™ offers a predictive solution to streamline depression treatment and enhance patient outcomes. The Challenge of Treating Depression Major depressive...